Care of patients with psoriasis: An audit of U.K. services in secondary care

British Journal of Dermatology

Volumn 160, Issue 3, 2009, Pages 557-564

  Eedy, D J ^a   Griffiths, C E M ^b   Chalmers, R J G ^b   Ormerod, A D ^c   Smith, C H ^d   Barker, J N W N ^d   Potter, J ^e   Ingham, J ^e   Lowe, D ^e   Burge, S ^f  

^a SOUTHERN HEALTH AND SOCIAL CARE TRUST   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^e ROYAL COLLEGE OF PHYSICIANS   (United Kingdom)

^f OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Audit; Dermatology; Psoriasis

Indexed keywords

INFLIXIMAB;

ADULT; ARTICLE; BIOLOGICAL THERAPY; CHILD; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL PSYCHOLOGY; CONSULTATION; DERMATOLOGY; DISEASE ASSOCIATION; DRUG MONITORING; EXERCISE; HEALTH CARE; HOSPITAL ADMISSION; HOSPITAL DEPARTMENT; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MEDICAL AUDIT; MEDICAL PROFESSION; OUTPATIENT DEPARTMENT; PHOTOTHERAPY; PHYSIOTHERAPIST; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PSORIASIS; QUALITY OF LIFE; QUESTIONNAIRE;

BIOLOGICAL PRODUCTS; CONSULTANTS; DELIVERY OF HEALTH CARE; DRUG UTILIZATION; HEALTH CARE SURVEYS; HEALTH SERVICES RESEARCH; HOSPITAL UNITS; HOSPITALIZATION; HUMANS; MEDICAL AUDIT; MEDICAL RECORDS; NURSING STAFF, HOSPITAL; OUTPATIENT CLINICS, HOSPITAL; PATIENT EDUCATION AS TOPIC; PRIMARY HEALTH CARE; PSORIASIS; REFERRAL AND CONSULTATION; WAITING LISTS;

EID: 60449112866     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08987.x     Document Type: Article

References (18)

1. Griffiths CEM, Barker JNWN. Pathogenesis and clinical features of psoriasis. Lancet 2007 21 : 263 71.
2. Griffiths CEM, Clark CM, Chalmers RJG et al. Systematic review of treatments for severe psoriasis. Health Technol Assess 2000 4 : 1 125. Available at http://www.ncchta.org/fullmono/mon440.pdf [last accessed 8 October 2008].
3. Naldi L, Griffiths CEM. Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks. Br J Dermatol 2005 152 : 597 615.
4. Menter A, Griffiths CEM. Current and future management of psoriasis. Lancet 2007 21 : 272 84.
5. Van de Kerkhof PC, Mrowietz U, Segaert S, Kragballe K. Comparative efficacy of topical antipsoriatic treatments, systemic treatment and biologics: is severity assessment beyond Psoriasis Area and Severity Index a necessity? Br J Dermatol 2007 156 : 771 2.
6. Smith CH, Anstey AV, Barker JN et al. British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005. Br J Dermatol 2005 153 : 486 97.
7. McKenna SP, Cook SA, Whalley D et al. Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials. Br J Dermatol 2003 149 : 323 31.
8. Hahn HB, Chuang TY. Using the Dermatology Index of Disease Severity (DIDS) to assess the responsiveness of dermatitis. Clin Exp Dermatol 2006 31 : 19 22.
9. Kirby B, Fortune DG, Bhushan M et al. The Salford Psoriasis Index: an holistic measure of psoriasis severity. Br J Dermatol 2000 142 : 728 32.
10. Department of Health. Hospital Episode Statistics England (1998-2005). Available at http://www.hesonline.nhs.uk?Ease?servlet?contentServer? siteID+1937&categoryID+2003 [last accessed 7 October 2008].
11. Woods AL, Rutter KJ, Gardner LS et al. Inpatient management of psoriasis: a multicentre service review to establish national admission standards. Br J Dermatol 2008 158 : 266 72.
12. Department of Health. The NHS Improvement Plan: Putting People at the Heart of Public Services. Available at http://www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH-4084516 [last accessed 7 October 2008].
13. British Association of Dermatologists. Staffing and Facilities for Dermatological Units. November 2006. Available at http://www.bad.org.uk/ healthcare/service/Staffing-and-Facilities-for-Dermatological-Units-Nov-2006. pdf [last accessed 7 October 2008].
14. British Association of Dermatologists. Psoriasis Guidelines, 2006. Available at http://www.bad.org.uk/healthcare/guidelines/psorintro.asp [last accessed 7 October 2008].
15. Workshop of the Research Unit of the Royal College of Physicians of London; Department of Dermatology, University of Glasgow; British Association of Dermatologists. Guidelines for management of patients with psoriasis. Brit Med J 1991 303 : 829 35.
16. Taylor DK, Anstey AV, Coleman AJ et al. Guidelines for dosimetry and calibration in ultraviolet radiation therapy: a report of a British Photodermatology group workshop. Br J Dermatol 2002 146 : 755 63.
17. National Statistics. UK Population Grows to 60,587,000 in Mid 2006. News release 22 August 2007. Available at http://www.statistics.gov.uk/cci/nugget. asp?ID=6 [last accessed 7 October 2008].
18. National Institute for Health and Clinical Excellence. Etanercept and Efalizumab for the Treatment of Adults with Psoriasis. NICE Technology Appraisal Guidance 103. Available at: http://www.nice.org.uk/guidance/index.jsp?action= download&o=33377 [last accessed 7 October 2008].